Guyasuta Investment Advisors Inc Pfizer Inc Transaction History

Guyasuta Investment Advisors Inc

$1.45 Billion
Q2 2024

A detailed history of Guyasuta Investment Advisors Inc transactions in Pfizer Inc stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 267,162 shares of PFE stock, worth $7.73 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

267,162

Previous 270,255 1.14%

Holding current value

$7.73 Million

Previous $7.5 Million 0.32%

% of portfolio

0.51%

Previous 0.51%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$25.26 - $29.6 $78,129 - $91,552	-3,093 Reduced 1.14%	267,162 $7.48 Million
Q1 2024 Apr 16, 2024	SELL	$25.89 - $29.73 $46,239 - $53,097	-1,786 Reduced 0.66%	270,255 $7.5 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $16.3 Million - $21.1 Million	-622,742 Reduced 69.6%	272,041 $7.83 Million
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $68,800 - $80,421	-2,144 Reduced 0.24%	894,783 $29.7 Million
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $356,973 - $413,010	-9,883 Reduced 1.09%	896,927 $32.9 Million
Q1 2023 Apr 28, 2023	BUY	$39.39 - $51.28 $327,567 - $426,444	8,316 Added 0.93%	906,810 $37 Million
Q4 2022 Jan 30, 2023	BUY	$41.75 - $54.5 $598,361 - $781,094	14,332 Added 1.62%	898,494 $46.1 Million
Q3 2022 Oct 25, 2022	BUY	$43.76 - $53.42 $123,315 - $150,537	2,818 Added 0.32%	884,162 $38.7 Million
Q2 2022 Jul 21, 2022	SELL	$46.53 - $55.17 $36,851 - $43,694	-792 Reduced 0.09%	881,344 $46.2 Million
Q1 2022 May 03, 2022	SELL	$45.75 - $56.69 $242,978 - $301,080	-5,311 Reduced 0.6%	882,136 $45.7 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $411,299 - $609,682	-9,954 Reduced 1.11%	887,447 $52.4 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $7,418 - $9,529	189 Added 0.02%	897,401 $38.6 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $761,974 - $863,188	21,219 Added 2.42%	897,212 $35.1 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $1.02 Million - $1.15 Million	30,483 Added 3.61%	875,993 $31.7 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $203,564 - $258,849	6,082 Added 0.72%	845,510 $31.1 Million
Q3 2020 Oct 28, 2020	SELL	$31.75 - $37.25 $20,637 - $24,212	-650 Reduced 0.08%	839,428 $30.8 Million
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $73,402 - $89,047	-2,437 Reduced 0.29%	840,078 $27.5 Million
Q1 2020 Apr 28, 2020	SELL	$27.03 - $38.62 $190,615 - $272,348	-7,052 Reduced 0.83%	842,515 $27.5 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $790,475 - $897,088	24,012 Added 2.91%	849,567 $33.3 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $904,489 - $1.17 Million	27,839 Added 3.49%	825,555 $28.1 Million
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $811,710 - $911,364	21,950 Added 2.83%	797,716 $34.6 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $291,562 - $320,330	-7,775 Reduced 0.99%	775,766 $32.9 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $92,674 - $105,658	2,409 Added 0.31%	783,541 $34.2 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $577,200 - $700,108	-16,745 Reduced 2.1%	781,132 $34.4 Million
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $15,038 - $16,032	456 Added 0.06%	797,877 $28.9 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $756,490 - $877,633	23,707 Added 3.06%	797,421 $28.3 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $103,272 - $109,575	-3,105 Reduced 0.4%	773,714 $28 Million
Q3 2017 Nov 09, 2017	SELL	$31.0 - $34.15 $204,476 - $225,253	-6,596 Reduced 0.84%	776,819 $27.7 Million
Q2 2017 Aug 09, 2017	BUY	N/A	783,415	783,415 $26.3 Million

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $162B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.

Account

Guyasuta Investment Advisors Inc Pfizer Inc Transaction History